Biological markers of neuroendocrine tumors of the gastrointestinal tract and pancreas. Clinical review

I. M. Modlin, S. A. Stoch, D. I. Soybel, O. Nilsson, H. Ahlman

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Based upon this cursory review of peptides and other substances which may act as markers for the presence of islet cell tumors or gastrointestinal carcinoids, certain themes seem to emerge. The first is that when these tumors are associated with endocrine syndromes, it is usually possible to attribute symptoms to the circulation of one dominant hormone. What is perhaps most remarkable is that one hormone can dominate the clinical picture, even if others are synthesized and secreted in excess. These tumors have clearly provided an opportunity to study mechanisms by which prohormones are synthesized and processed within secretory granules. A second theme is that many of these neoplasms express receptors for regulation of their secretory activities. Thus, most of the neuroendocrine tumors of the gut are responsive to secretory suppression by somatostatin. It is curious that a number of these lesions show a heightened responsiveness to certain secretagogues such as calcium ion and secretin. The explanation of such observations may lead to a greater understanding of the mechanisms, which regulate the response of the normal endocrine cell to secretory stimulation. A third theme is that a large number of specific peptides, amines, and enzymes can be detected in plasma samples or tissue preparations, which identify the neuroendocrine origin of these tumors. Nevertheless, few, if any, of these markers has as yet been shown to reliably distinguish the invasive or metastatic potential of such tumors. These observations might suggest that the machinery for synthesizing and secreting currently recognizable hormones has little to do with the properties which lead to cell proliferation, tumor invasiveness or potential for metastasis. If this were so, it is difficult to explain why some tumors secrete their hormone and prohormone products to such excess, and others do not. In this regard, the MEN syndromes may well provide the most intriguing models for studying the relationship of proliferation and neoplastic transformation of endocrine cells to synthesis and secretion of their hormone and monoamine products. The identification of specific growth factors in neuroendocrine tumors may be an important area for developing predictive indices of mitogenic rate, biosecretory activity, and angiogenic invasion.

Original languageEnglish (US)
Pages (from-to)629-645
Number of pages17
JournalActa Chirurgica - European Journal of Surgery
Volume157
Issue number11-12
StatePublished - Dec 1 1991

Fingerprint

Neuroendocrine Tumors
Gastrointestinal Tract
Pancreas
Biomarkers
Hormones
Neoplasms
Endocrine Cells
Islet Cell Adenoma
Peptides
Secretin
Carcinoid Tumor
Secretory Vesicles
Somatostatin
Amines
Intercellular Signaling Peptides and Proteins
Cell Proliferation
Ions
Neoplasm Metastasis
Calcium
Enzymes

All Science Journal Classification (ASJC) codes

  • Surgery

Cite this

@article{4adc904a732e44b89fe1a5b95d3ade14,
title = "Biological markers of neuroendocrine tumors of the gastrointestinal tract and pancreas. Clinical review",
abstract = "Based upon this cursory review of peptides and other substances which may act as markers for the presence of islet cell tumors or gastrointestinal carcinoids, certain themes seem to emerge. The first is that when these tumors are associated with endocrine syndromes, it is usually possible to attribute symptoms to the circulation of one dominant hormone. What is perhaps most remarkable is that one hormone can dominate the clinical picture, even if others are synthesized and secreted in excess. These tumors have clearly provided an opportunity to study mechanisms by which prohormones are synthesized and processed within secretory granules. A second theme is that many of these neoplasms express receptors for regulation of their secretory activities. Thus, most of the neuroendocrine tumors of the gut are responsive to secretory suppression by somatostatin. It is curious that a number of these lesions show a heightened responsiveness to certain secretagogues such as calcium ion and secretin. The explanation of such observations may lead to a greater understanding of the mechanisms, which regulate the response of the normal endocrine cell to secretory stimulation. A third theme is that a large number of specific peptides, amines, and enzymes can be detected in plasma samples or tissue preparations, which identify the neuroendocrine origin of these tumors. Nevertheless, few, if any, of these markers has as yet been shown to reliably distinguish the invasive or metastatic potential of such tumors. These observations might suggest that the machinery for synthesizing and secreting currently recognizable hormones has little to do with the properties which lead to cell proliferation, tumor invasiveness or potential for metastasis. If this were so, it is difficult to explain why some tumors secrete their hormone and prohormone products to such excess, and others do not. In this regard, the MEN syndromes may well provide the most intriguing models for studying the relationship of proliferation and neoplastic transformation of endocrine cells to synthesis and secretion of their hormone and monoamine products. The identification of specific growth factors in neuroendocrine tumors may be an important area for developing predictive indices of mitogenic rate, biosecretory activity, and angiogenic invasion.",
author = "Modlin, {I. M.} and Stoch, {S. A.} and Soybel, {D. I.} and O. Nilsson and H. Ahlman",
year = "1991",
month = "12",
day = "1",
language = "English (US)",
volume = "157",
pages = "629--645",
journal = "British Journal of Surgery",
issn = "0007-1323",
publisher = "John Wiley and Sons Ltd",
number = "11-12",

}

Biological markers of neuroendocrine tumors of the gastrointestinal tract and pancreas. Clinical review. / Modlin, I. M.; Stoch, S. A.; Soybel, D. I.; Nilsson, O.; Ahlman, H.

In: Acta Chirurgica - European Journal of Surgery, Vol. 157, No. 11-12, 01.12.1991, p. 629-645.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Biological markers of neuroendocrine tumors of the gastrointestinal tract and pancreas. Clinical review

AU - Modlin, I. M.

AU - Stoch, S. A.

AU - Soybel, D. I.

AU - Nilsson, O.

AU - Ahlman, H.

PY - 1991/12/1

Y1 - 1991/12/1

N2 - Based upon this cursory review of peptides and other substances which may act as markers for the presence of islet cell tumors or gastrointestinal carcinoids, certain themes seem to emerge. The first is that when these tumors are associated with endocrine syndromes, it is usually possible to attribute symptoms to the circulation of one dominant hormone. What is perhaps most remarkable is that one hormone can dominate the clinical picture, even if others are synthesized and secreted in excess. These tumors have clearly provided an opportunity to study mechanisms by which prohormones are synthesized and processed within secretory granules. A second theme is that many of these neoplasms express receptors for regulation of their secretory activities. Thus, most of the neuroendocrine tumors of the gut are responsive to secretory suppression by somatostatin. It is curious that a number of these lesions show a heightened responsiveness to certain secretagogues such as calcium ion and secretin. The explanation of such observations may lead to a greater understanding of the mechanisms, which regulate the response of the normal endocrine cell to secretory stimulation. A third theme is that a large number of specific peptides, amines, and enzymes can be detected in plasma samples or tissue preparations, which identify the neuroendocrine origin of these tumors. Nevertheless, few, if any, of these markers has as yet been shown to reliably distinguish the invasive or metastatic potential of such tumors. These observations might suggest that the machinery for synthesizing and secreting currently recognizable hormones has little to do with the properties which lead to cell proliferation, tumor invasiveness or potential for metastasis. If this were so, it is difficult to explain why some tumors secrete their hormone and prohormone products to such excess, and others do not. In this regard, the MEN syndromes may well provide the most intriguing models for studying the relationship of proliferation and neoplastic transformation of endocrine cells to synthesis and secretion of their hormone and monoamine products. The identification of specific growth factors in neuroendocrine tumors may be an important area for developing predictive indices of mitogenic rate, biosecretory activity, and angiogenic invasion.

AB - Based upon this cursory review of peptides and other substances which may act as markers for the presence of islet cell tumors or gastrointestinal carcinoids, certain themes seem to emerge. The first is that when these tumors are associated with endocrine syndromes, it is usually possible to attribute symptoms to the circulation of one dominant hormone. What is perhaps most remarkable is that one hormone can dominate the clinical picture, even if others are synthesized and secreted in excess. These tumors have clearly provided an opportunity to study mechanisms by which prohormones are synthesized and processed within secretory granules. A second theme is that many of these neoplasms express receptors for regulation of their secretory activities. Thus, most of the neuroendocrine tumors of the gut are responsive to secretory suppression by somatostatin. It is curious that a number of these lesions show a heightened responsiveness to certain secretagogues such as calcium ion and secretin. The explanation of such observations may lead to a greater understanding of the mechanisms, which regulate the response of the normal endocrine cell to secretory stimulation. A third theme is that a large number of specific peptides, amines, and enzymes can be detected in plasma samples or tissue preparations, which identify the neuroendocrine origin of these tumors. Nevertheless, few, if any, of these markers has as yet been shown to reliably distinguish the invasive or metastatic potential of such tumors. These observations might suggest that the machinery for synthesizing and secreting currently recognizable hormones has little to do with the properties which lead to cell proliferation, tumor invasiveness or potential for metastasis. If this were so, it is difficult to explain why some tumors secrete their hormone and prohormone products to such excess, and others do not. In this regard, the MEN syndromes may well provide the most intriguing models for studying the relationship of proliferation and neoplastic transformation of endocrine cells to synthesis and secretion of their hormone and monoamine products. The identification of specific growth factors in neuroendocrine tumors may be an important area for developing predictive indices of mitogenic rate, biosecretory activity, and angiogenic invasion.

UR - http://www.scopus.com/inward/record.url?scp=0026351912&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026351912&partnerID=8YFLogxK

M3 - Review article

AN - SCOPUS:0026351912

VL - 157

SP - 629

EP - 645

JO - British Journal of Surgery

JF - British Journal of Surgery

SN - 0007-1323

IS - 11-12

ER -